ArticleEcancermedicalscience2025
Region-wise pattern of demographic, clinicopathological and treatment profile of thyroid cancers from 96 hospital-based cancer registries in India.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Thyroid cancer (TC) is the most pervasive endocrine cancer worldwide. We examined the region-wise pattern of TC in India according to demographic, clinicopathological treatment and waiting-time distribution from diagnosis to treatment. Methods: TC cases in India from 96 hospital-based cancer registries (HBCRs) (North 28, East 8, West 7, South 40, Central 4 and North-East 9) reported for 2012-2019 were included. Among the 31,678 newly diagnosed cases, those treated only at the respective HBCR's ( Results: Among the 10,521 cases, 58% were from the South, the majority (68%) were females, with female-to-male ratio of 4.3:1, 3.8:1 and 3.5:1 in the north-east, central and southern regions, respectively, in the youngest (<35 years) age group ( Conclusion: We observed considerable heterogeneity in demographic, clinic-pathological, treatment and waiting time from diagnosis to treatment for TC across the regions in India; this kind of region-wise hospital-based analysis would help to improve national and local cancer care programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.